Meet In CommonNewsRSS feeds

Local

Opinions: President Goldsmith’s ‘Silicon Island’ dream leaves the humanities stranded

A Roundtable is a way to meet new people and discuss this article in person at a local coffee shop or other venue.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

Source: The Stony Brook Statesman

When Stony Brook University President Andrea Goldsmith discusses artificial intelligence, she paints a picture of Stony Brook as a tech powerhouse. Her administrative vision through her ASPIRE 2035 plan framed AI as a catalyst for institutional prestige and pitched goals to turn the University into a global hub for technology and innovation, what she calls a “Silicon Island.” The message from the Goldsmith administration is clear: Stony Brook is charging full speed ahead into a technological future. Yet, the future Goldsmith illustrates is remarkably one-sided: STEM-sided. In her recent Homecoming Thought Leadership Series, she hosted a panel called, “The AI Revolution at Stony Brook: How Seawolves Are Deploying AI Across All Facets of Our Mission.” In this panel, microphones were passed around to engineering faculty, hospital administrators and leaders in technology.

This excerpt comes from the named source. Read the original for the full reporting.

Read the original at The Stony Brook Statesman

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

Community Poll

Paid endorsements should be clearly distinguished from independent recommendations.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

Would you want a doctor to give you a fake pill if the lie might make you feel better?

A patient has persistent symptoms that have not responded to standard treatments. A harmless placebo may help, but its effect could weaken if the clinician fully explains that it contains no active medicine.

Can a beneficial deception respect the person it helps?

Explore this quandary